Neonatal Sepsis Platforms and Guidelines (Session 12 – 4th World Sepsis Congress)
Neonatal Sepsis Platforms and Guidelines (Session 12 – 4th World Sepsis Congress)
Session 12 from the 4th World Sepsis Congress. To go directly to a specific speaker/talk, please use these chapter markers:00:00 Intro
00:34 Odiraa Nwankwor – Introduction
01:16 Ramanan Laxminarayan – Disproportionate Burden of AMR Excess Deaths Experienced by Neonates in Low- and Middle-Income Countries
14:46 Vanessa Quan – Incidence and Burden of Neonatal Sepsis in South Africa
28:02 Jeeva Sankar – Neonatal Sepsis and Treatment Challenges in India
43:30 Uduak Okomo – Invasive Bloodstream Infections and AMR in Africa: Approaches to Treatment and Next Steps
1:01:21 Julia Bielicki – Next Steps for NeoSep
All talks are also available as a podcast – just search for World Sepsis Congress in your podcast app of choice.
Direct link: https://podcasts.apple.com/us/podcast/4th-world-sepsis-congress/id1155062518
Session 11 is already available. Sessions 13 and 14 will follow on June 13, 2023. The full release schedule is available at https://www.worldsepsiscongress.org/watch
Thanks for watching and sharing.
The 4th World Sepsis Congress – One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance is a project by the Global Sepsis Alliance, initiator of World Sepsis Day and World Sepsis Congress.
Stop Sepsis – Save Lives
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.